Free tool
FAERS Monitor: Duopa
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 203952 or its brand name (Duopa, Carbidopa, Levodopa). Reports on generic versions are filed under their own applications.
Reports
13,728
Serious
9,593
70% of reports
Hospitalization
5,279
Death reported
1,774
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fall1,708
- death1,028
- device issue945
- drug ineffective881
- parkinson^s disease805
- device dislocation803
- hallucination788
- dyskinesia781
- urinary tract infection609
- tremor600
- asthenia586
- device occlusion508
- gait disturbance506
- weight decreased503
- stoma site discharge446
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 96 |
| 2005 | 92 |
| 2006 | 85 |
| 2007 | 107 |
| 2008 | 224 |
| 2009 | 122 |
| 2010 | 150 |
| 2011 | 141 |
| 2012 | 134 |
| 2013 | 31 |
| 2014 | 67 |
| 2015 | 314 |
| 2016 | 757 |
| 2017 | 859 |
| 2018 | 973 |
| 2019 | 1,075 |
| 2020 | 1,369 |
| 2021 | 1,444 |
| 2022 | 1,770 |
| 2023 | 1,163 |
| 2024 | 1,060 |
| 2025 | 1,112 |
| 2026 | 583 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,431 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| stoma site dischargeSignal | 446 | 298.0 | 269.6 | 110,287 |
| device occlusionSignal | 508 | 57.3 | 52.6 | 27,070 |
| dyskinesiaSignal | 781 | 30.0 | 28.0 | 21,486 |
| device dislocationSignal | 803 | 28.8 | 26.9 | 21,175 |
| device issueSignal | 945 | 16.3 | 15.3 | 13,476 |
| hallucinationSignal | 788 | 16.2 | 15.1 | 11,128 |
| fallSignal | 1,708 | 7.9 | 7.6 | 10,395 |
| tremorSignal | 600 | 5.6 | 5.1 | 2,246 |
| urinary tract infectionSignal | 609 | 5.5 | 5.1 | 2,240 |
| gait disturbanceSignal | 506 | 4.1 | 3.7 | 1,171 |
| weight decreasedSignal | 503 | 2.8 | 2.5 | 571 |
| astheniaSignal | 586 | 2.4 | 2.2 | 480 |
| death | 1,028 | 1.8 | 1.7 | 402 |
| drug ineffective | 881 | 1.0 | 1.0 | 1 |
| parkinson^s disease | 805 | 0.0 | 0.0 | 1,232,310 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.